MedTrace Logo

Autism Biomarker Consortium for Clinical Trials (ABC-CT): Follow-up Study

NCT04841525 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 265

Last updated 2023-04-05

No results posted yet for this study

Summary

This is a multicenter longitudinal follow-up study to the main study of an a registered already (NCT# ). The Follow-up Study (T4) will assess the Main Study cohort for an additional longitudinal time point approximately 2-5 years after the initial study. Children participating in the Follow-up Study will be approximately 8-16 years old.

The aims of the main study is to identify, develop and validate a set of measures that can be used as stratification biomarkers and/or sensitive and reliable objective measures of social impairment in autism spectrum disorders (ASD) that could serve as markers of long term clinical outcome.

Conditions

Sponsors & Collaborators

Principal Investigators

  • James McPartland, PhD · Yale University Child Study Center

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-09
Primary Completion
2022-08-11
Completion
2022-08-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04841525 on ClinicalTrials.gov